Terry Smith acquired 3.62 Million Idexx Laboratories shares worth $1.18 Billion. That's 5.31% of their entire equity portfolio (7th largest holding). The investor owns 4.27% of the outstanding Idexx Laboratories stock. The first Idexx Laboratories trade was made in Q1 2015. Since then Terry Smith bought shares eighteen more times and sold shares on eleven occasions. The stake costed the investor $503 Million, netting the investor a gain of 134% so far.